Genetic prodrug activation therapy (GPAT) is an innovative approach that can kill tumour cells by inserting suicide genes into cancer cells. The cancer cells then use their cellular machinery to convert an otherwise benign exogenous substance (prodrug) into an agent that is cytotoxic to the cell. Current gene transfer technologies do not allow 100% of cells to be transfected. Therefore, critical to the success is the`bystander effect', which confers cytotoxicity on neighbouring untransfected cells. Tumour cells can then be killed effectively without the delivery to and expression of suicide genes in every tumour cell. Adenoviral vectors using the herpes simplex virus thymidine kinase/ganciclovir (HSVtk/GCV) system are being used increasingly. In order to establish the susceptibility of prostate cell lines to adenoviral transfection we have used an adenoviral vector containing green¯uorescent protein (GFP) to transfect nine human prostate cell lines (benign and malignant) and two rat prostate cell lines.
Method
The cell lines were exposed to the replication-de®cient adenoviral vector (cytomegalovirus, CMV) containing GFP (Ad5-CMV-GFP) at PFU : cell ratios ranging from 0 to 1000. The cells were exposed to the virus for 4 h and then virus was removed and replaced with normal medium. GFP expression was assessed after 24, 48 and 72 h using FACScan analysis. Cell viability, using a standard MTT assay, was also assessed to ensure the virus had no toxic effects, even at the higher PFU : cell ratios.
Results
All the cell lines showed a dose-dependent increase in GFP expression with increasing PFU : cell ratio. The cell lines showed variability in susceptibility to transfection. LnCAP was the most susceptible line to transfection, with 99% of cells GFP positive at 100 PFUs per cell, and even at 1 PFU per cell, 60% of cells expressed GFP. The virus appeared to have no toxic effects on the cells even at the ratio of 1000 PFUs per cell.
Conclusion
This preliminary work shows that adenoviral vectors are acceptable for transfection of prostate cells. The level of transfectability is however highly variable between cell lines and therefore the mechanism of transfection and thè bystander effect' needs to be explored in these cell lines. We are currently working on these areas and have also commenced work using Ad-CMV-HSVtk in these cell lines.
